From the University Hospital Düsseldorf, cases of stable remission in patients with HIV have been identified for more than a decade after transplantation of genetically modified bone marrow cells. This diet is the hope of creating an anti-HIV therapy that can be guaranteed to fight this ailment. For instruments with CRISPR, you may find that there are no milk caps on the mashtabs.
The story of the “Düsseldorf Patient” began with myeloid leukemia in 2008. A few years later, he was also diagnosed with HIV. German doctors decided to use this case to test the idea that both diseases can be cured by transplanting cells with an altered CCR5 gene. They specially selected a donor with a new mutation, and in 2013 it turned out to be a cell transplant.
A mutation in CCR5 is found in a genetic region that is responsible for docking cells with HIV, which prevents its spread, but the main thing is that the virus can no longer “hide” inside cells in order to renew itself after treatment. This mechanism also works to counteract leukemia. Previously, “London” and “Berlin” patients were detected from HIV in the same way, but earlier scientists did not have the opportunity to control the state of the genome of cells for transplantation.
Success in treating a third person for HIV opens up incredible opportunities for medicine. If earlier you had to select the right summer material or p p p given.
Source: Tech Cult
I am a professional journalist and content creator with extensive experience writing for news websites. I currently work as an author at Gadget Onus, where I specialize in covering hot news topics. My written pieces have been published on some of the biggest media outlets around the world, including The Guardian and BBC News.
